Special Report I
Issue15_November 2017
C&R Research Inc., Korea’s leading contract research organization (CRO), has launched its major global initiative by establishing C&R Healthcare Global Pte. Ltd., a subsidiary company specialized in promoting global business partnerships and securing investments. The initiative will facilitate licensing, strategic partnerships and investment opportunities for promising bio-pharmaceutical companies based in Korea.
C&R Research has partnered with Korea’s health and medical industries in clinical development for the past 20 years, since its foundation in 1997. To date, C&R Research has carried out a total of 1,200 clinical trials, coupled with drug license services, thus emerging as Asia’s representative CRO beyond Korea.
On October 13th 2017, C&R Healthcare Global completed a MOU with W Medical Strategy Group, a New York based consulting firm with diverse medical and pharmaceutical networking portfolio, to further explore global strategic partnerships.
Under the new partnership, W Medical Strategy Group supports global outreach of C&R Research and provides strategic consulting to provide an essential bridgehead in North America for Korean bio-pharmaceutical industry.
C&R Healthcare Global provides service to biohealth companies and recruits companies to move into Singapore Incubating Center. Detailed information can be found at C&R Healthcare Global official webpage at www.cnrhg.asia.
